Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Oct;46(4):670–674. doi: 10.1038/bjc.1982.253

The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.

N J McNally
PMCID: PMC2011195  PMID: 6291565

Full text

PDF
670

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. M. The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):675–682. doi: 10.1016/0360-3016(82)90711-8. [DOI] [PubMed] [Google Scholar]
  2. George K. C., Hirst D. G., McNally N. J. Effect of hyperthermia on cytotoxicity of the radiosensitizer Ro-07-0582 in a solid mouse tumour. Br J Cancer. 1977 Mar;35(3):372–375. doi: 10.1038/bjc.1977.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Grigsby P., Maruyama Y. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole. Br J Radiol. 1981 Nov;54(647):969–972. doi: 10.1259/0007-1285-54-647-969. [DOI] [PubMed] [Google Scholar]
  4. Martin W. M., McNally N. J., De Ronde J. Enhancement of the effect of cytotoxic drugs by radiosensitizers. Br J Cancer. 1981 Jun;43(6):756–766. doi: 10.1038/bjc.1981.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. McNally N. J. Enhancement of chemotherapy agents. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):593–598. doi: 10.1016/0360-3016(82)90691-5. [DOI] [PubMed] [Google Scholar]
  6. McNally N. J., Stephens T. C., Twentyman P. R., Hinchliffe M., Peacock J. H., Spooner D. The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):659–662. doi: 10.1016/0360-3016(82)90707-6. [DOI] [PubMed] [Google Scholar]
  7. Rojas A., Stewart F. A., Denekamp J. Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection. Br J Cancer. 1982 May;45(5):684–693. doi: 10.1038/bjc.1982.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Stewart F. A., Rojas A. Radioprotection of mouse skin by WR-2721 in single and fractionated treatments. Br J Radiol. 1982 Jan;55(649):42–47. doi: 10.1259/0007-1285-55-649-42. [DOI] [PubMed] [Google Scholar]
  9. Travis E. L., De Luca A. M., Fowler J. F., Padikal T. N. The time course of radioprotection by WR 2721 in mouse skin. Int J Radiat Oncol Biol Phys. 1982 May;8(5):843–850. doi: 10.1016/0360-3016(82)90087-6. [DOI] [PubMed] [Google Scholar]
  10. Twentyman P. R. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721. Br J Cancer. 1981 Jun;43(6):745–755. doi: 10.1038/bjc.1981.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wasserman T. H., Phillips T. L., Ross G., Kane L. J. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721. Cancer Clin Trials. 1981;4(1):3–6. [PubMed] [Google Scholar]
  12. Yuhas J. M. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1980 May;40(5):1519–1524. [PubMed] [Google Scholar]
  13. Yuhas J. M., Culo F. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties. Cancer Treat Rep. 1980 Jan;64(1):57–64. [PubMed] [Google Scholar]
  14. Yuhas J. M. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine. Cancer Treat Rep. 1979 Jun;63(6):971–976. [PubMed] [Google Scholar]
  15. Yuhas J. M., Spellman J. M., Jordan S. W., Pardini M. C., Afzal S. M., Culo F. Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide. Br J Cancer. 1980 Oct;42(4):574–585. doi: 10.1038/bjc.1980.282. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES